Preliminary experiments were initiated to test the attenuation for mice of chemically induced temperature-sensitive (Ets) mutants of a virulent strain of Eastern encephalitis (E) virus, and the potential of such mutants as live virus vaccines for mice. The reversion frequencies of eight mutants to temperature insensitivity were measured and the defects in their biosynthesis at the nonpermissive temperature were studied. All eight mutants were less virulent for mice, but the extent of avirulence varied with the mutant and route of injection. The mutants selected as potential vaccines protected mice against subsequent challenge at IO to zi days by the virulent virus of strain E. Neutralizing antibody activity was detected in almost all of the mutant-infected mice after I o days, and was found in all infected mice at 2I days. Immunization by two doses of virus induced a very high protection against intracerebral challenge by virus strain E.
Most live virus vaccines are produced from viruses that are genetically altered from a wild type strain of greater virulence. To be effective as a live vaccine a virus must be avirulent for the host to be vaccinated so that the clinical signs or symptoms are likely to be tolerable or absent in most cases. At the same time, the selected strain must induce an immune response sufficient to protect the host against a subsequent natural infection. Continuous passage in animals or in cell culture has been the most common method of virus attenuation. Such experiments were usually entirely uncontrolled and empirical, based on the expectation that mutations or selections would allow an attenuated population of viruses to emerge. This approach has been successful in several cases (Theiler, I95I ; Enders et aL 196o; Sabin, I96I) .
Recent approaches have involved passages in cell culture at an incubation temperature below 37 °C, since, as suggested principally by Lwoff 0959), there is frequently an association of virus avirulence with an inability to multiply well at normal or high (e.g. fever) temperatures. This approach, like the first, results in the random emergence of variants during extensive serial passage; further, there has frequently been no significant analysis of the mutational or selection steps involved, or of the stability or priority of the avirulent strains produced. The advent of chemical mutagenic agents for viruses (Thiry, 1963; Burge & Pfefferkorn, I966; Halle, I968) , the development of the plaque assay for animal viruses (Dulbeco & Vogt, I953) and the definition of genetic lesions, have provided methods for the rapid recognition and analysis of mutants at reasonable frequency. The two most easily handled markers have been small plaque type (Hardy & Hearn, I96I; Thiry, I963; Colter, Campbell & Hatch, 1965; Brown & Officer, I974) , and temperature sensitivity (ts) (Burge & Pfefferkorn, I966; Maasab et aL I969; Simizer & Takoyoma, I972; Wagner, I974) .
We have isolated ts mutants of Eastern encephalitis virus (E) after induction by two chemical mutagens. The genetic defects of the Ets mutants have been studied and their reversion frequencies to temperature insensitivity have been determined. In the present report, we emphasize the attenuation of the mutants and their properties as vaccines in mice.
The parent Louisiana strain of E has been well characterized (Brown, I963) . It was prepared as a stock suspension after infection of chick embryo cells (CEC) with 5 to 50 p.f.u./ plate following plaque purification. It is highly virulent for weanling mice by several routes of injection.
For selecting ts mutants, E virus was treated with nitrous acid directly in suspension in the absence of cells, or by 5-azacytidine during replication in CEC (Burge & Pfefferkorn, 1966; Halle, 1968) . The surviving virus populations were then plaqued at 3o °C. This was followed by further sub-plaquing from each individual plaque onto two duplicate plates which were ' geographically' marked for later identification. The plates were then divided for incubation at 3o and 4 z °C. Plaques which appeared at 30 °C but not at 42 °C were plaque purified three times before stocks were made after infection by 5 to 5o p.f.u./plate of CEC and tested for their ts property of ability to form plaques at 30 °C but not 42 °C, and their comparative replication in liquid medium at both temperatures. A less laborious method for isolation of mutants was used in half the experiments in which the initial plaquing after chemical treatment was at 37 °C for 36 to 48 h and then shifted to 42 °C for 24 h; only relatively small plaques (0"5 to 0-8 ram) were picked for further testing. This was followed by plaque purification, and re-testing. The small plaques, recovered immediately after mutagenesis by the second method, were studied further and found to be: (I) authentic ts mutants; (2) phenotypically small because they were' late starters' or at the' small' end of a normal distribution of plaque size; (3) genetically determined as small because of sensitivity to the inhibitor in agar (Colon et al. I965; Colter et al. 1965) ; (4) sterile (no virus recovered), presumably because an outer coat protein was sensitive to heat denaturation at 3 o °C (Burge & Pfefferkorn, 1966) . The second technique yielded mutant isolations more easily, although probably at the expense of some RNA + mutants as in (4) above. Stocks of each mutant were characterized with respect to: (I) Reversion frequency (ratio of p.f.u./ml at 4z °C to p.f.u./ml at 3o °C); (2) efficiency of replication in liquid cultures after incubation for i2 h at 4z °C following infection at an input multiplicity of 5 p.f.u./cell, and (3) ability to induce virus RNA synthesis in infected cells as measured by uptake of radioactive uridine in the presence of #g/ml of actinomycin D (Zebovitz & Brown, I97o) . Stock populations of mutants were discarded if more than one virus in lO 4 formed plaques at both 42 and 3 ° °C, or if virus yield in IZ h at 42 °C was more than 3 ~o of that shown by the virulent strain E.
The virulence or avirulence of a virus shown in a given route is defined as the ratio of p.f.u./LDso or loglo (p.f.u./LDs0). The LDao was determined by the method of Reed & Muench (I938) .
Ets mutants were used to immunize 8 to lZ g weanling Swiss Webster mice by one injection by the s.c. or i.p. route, or by two injections by the i.p. route, IO days apart. Challenges were made with virulent E by one or more routes I o or 2 t days after vaccination. Protection is expressed as a protective index (PI) equal to log10 (LD~o/ml) in control (shamimmunized) mice minus the logx0 (LDso/ml) in mutant-immunized mice. A PI of I.O or greater is considered significant and o. 7 to o'9 marginal (Brown & Officer, I974) . In all experiments where infectivities as LDso]ml and]or PI's were determined, tenfold dilutions of stock virus were used with Io mice per dilution.
The activity of neutralizing antibody was estimated on ascites fluids or serum taken from three immunized and control mice each by a standard plaque neutralization test, and by an antiglobulin plaque neutralization (AGN) test (Brown et al. 1969) . The AGN test involves a second incubation of a goat anti-mouse y globulin following the standard virus-antibody 9"8 (o'3)* 3"9 5"3 9"7 i.o 4"7 7"o 9"9 3'4 8.1 8"4 9'9 t'4 5"7 7"6 9"8 I.
2. 7 6. 5 7.0 * Bracketed differences less than I .o are not considered significant. incubation that is normally carried out in the neutralization test. The AGN test frequently detects antibody sooner or at higher activity (z to 2o fold) than the neutralization test (Brown et aL I969) .
Eight ts mutants that were isolated were characterized by their reversion frequencies and ability to induce virus RNA synthesis at 42 °C prior to determining their virulence. Reversion frequencies ranged from 5 x IO -~ (Ets5) to below xo -7 (Ets2). Only one mutant (Ets4) induced virus RNA synthesis at the non-permissive temperature of 42 °C. This mutant has been further characterized biochemically (Zebovitz & Brown, 197o) .
Virulence, defined as log10 (p.f.u./LDs0), was determined for each virus (Bradish, Allner & Maber, 1972) . From the analysis of the results in Table I , it may be seen that all the described viruses, including parent E, are substantially avirulent for mice by the i.p. route (range = 3"9 to 8.2), even less virulent by the s.c. route (5"3 to 8"4), and least attenuated by the i.c. route (I.O to 3"4). It appears that Ets2 and Ets7 are indistinguishable and are the least virulent of the mutants by all the routes of injection. However, they show significantly different reversion frequencies (Ets2 = < IO-7; Ets7 = 2 x io-~), different plaque diam. by 72 h (Ets2 = I'7 mm; Ets7 = 3"3 mm) and quantitative differences in their abilities to induce protection (Table 2) .
I 14 Short communications
Four of the mutants were chosen for comparison as vaccine strains for mice. Etsz and Ets7 were selected because they were the least virulent and appeared to be different. Ets4 was selected because it was the sole representative of the RNA + class of ts mutants, and because it was an especially good interfering virus in cell culture (Zebvotiz & Brown, I968) . Ets6 was selected because it represented one of the least attenuated mutants by the i.c. route, and might provide a chance that at least this mutant would not be so attenuated as to provide no protection (Hammon et al. I966) .
In these experiments, the mice were immunized once with each mutant by the i.p. or s.c. route. Challenges with virus E were at Io or 2I days later by the i.c., i.p. or s.c. route. The results at IO days in Table 2 show the following: (I) all the mutants induced significant protection against virus E for any route of challenge io days after immunization; (2) Ets2 immunized most effectively against challenge by the i.e. route; (3) Ets6, the mutant least attenuated for mice by the i.c. route, but substantially attenuated by the i.p. and s.c. routes, provided the least protection against challenge with virus E by the i.c. route following i.p. immunization. The results at 2I days show the following: (0 all the mutants induced significant protection by the s.c. route of immunization; (2) the level of protection for some mutants was less for challenge at 2I days than at Io days.
The protection induced by the single i.p. immunization of the mutants permitted us to immunize a second time with as much as Io 7 p.f.u, of virus Io days after the first immunization. The results for the mutants that were tested (Ets2 and Ets4) showed that very high protective indices by the i.e. route of challenge could be achieved (6.8 for Ets2 and 5"5 for Ets4) that were not attainable by a single immunization with a lower dose of Io 5 p.f.u.
Neutralizing antibody titres of pooled ascites fluids measured by the two neutralization tests could, except for two cases, be detected at Io and 2I days after a single immunization and after the two immunizations described above. The titres ranged from < I/1o by the standard test at Io days (for two mutants, Ets and Ets7) to about I/Ioooo as detected by the AGN test after two immunizations (Ets4). However, no correlations could be made between the neutralizing antibody titres determined by either method used, and the protective indices.
Choices for the selection of infectious ts mutants as potential vaccines are usually made so that virus replication can occur and induce antibody formation and immunity yet not cause 'unacceptable' symptoms or pathology. The initial results of testing the virulence and vaccine potential of the Ets mutants show that all the mutants were attenuated and, after a single immunizing dose, were able to induce protection against challenge by more virulent parent E virus. Although neutralizing antibody activity was detected after almost all immunizations, no meaningful correlation could be made between antibody titres determined by either of the two methods used, and protective indices by any route of challenge. Aside from technical considerations that might account for the failure to observe such correlations (e.g. by appropriate statistically designed experiments), there may be other reasons. For example, it has recently become clear that a cell mediated immune (CMI) response has been detected by in vitro tests after a single infection of mice by Sindbis virus (Griffin & Johnson, I973; McFarland, I974) , and also in vivo in lymphoid cell-adoptive transfer experiments in mice (Peck, Brown & Wust, I975) . Tile latter involved heterologous (cross) protection between two group A arboviruses (Sindbis & Semliki Forest) in the absence of cross neutralizing antibodies. The role of CMI vis/~ vis neutralizing antibody in homologous protection remains to be determined, and the role of CMI in heterologous protection among group A arboviruses requires confirmation and extension.
An overall evaluation &all the mutants suggests that Ets2 would be the virus of choice for An observation of some interest with Ets2 is its low ti reversion frequency in cell culture (below lO -7) concomitant with its lower (than E), but still significant, virulence for mice by the i.c. route. This suggests that the temperature in the mouse brain after infection by the i.c. route remains low enough to permit virus replication of the mutant sufficient to cause pathology and death, or that ti revertants are rapidly selected in the mouse during replication of the mutant. The first explanation seems more likely, because mouse brain suspensions obtained from two different groups of dead mice infected with Ets2 by the i.c. route in two different experiments had ti reversion frequencies below Io -7, like the stock Ets2 virus suspension. No effort has yet been made to determine the role of the possible production of defective interfering (DI) particles in the mouse in relation to our ts mutants and/or to attenuation (e.g. Huang & Baltimore, I97o; Shenk & Stollar, I973) . Very recent data (Dr John Holland, Annual Meeting, Infectious Diseases Society of America, 1974) suggests that ts mutants of vesicular stomatitis virus have a much greater tendency to give rise to DI particles in cell cultures than temperature-insensitive viruses. The stock virus preparations that we used, however, should theoretically have contained a minimal number of DI particles because of their preparation with low inocula after plaqeu purification, the standard method that is used to minimize DI particle appearance in virus'stocks.
